Literature DB >> 19058854

cAMP regulates IL-10 production by normal human T lymphocytes at multiple levels: a potential role for MEF2.

Kassiani Liopeta1, Stavroula Boubali, Laura Virgilio, George Thyphronitis, George Mavrothalassitis, George Dimitracopoulos, Fotini Paliogianni.   

Abstract

Signal transduction by the cAMP/cAMP-dependent protein kinase A (PKA) pathway is triggered through multiple receptors and is important for many processes in a variety of cells. In T cells, the engagement of the TCR-CD3 complex induces cAMP, a second messenger that controls immune response. IL-10, produced by a variety of lymphocyte subpopulations, is an important regulator of this response exerting a wide range of immunomodulatory actions. Elevation of cAMP has been shown to increase IL-10 production by monocytes. However, the mechanism of cAMP mediated regulation of IL-10 production by T lymphocytes remains unclear. In this study using normal peripheral T lymphocytes stimulated either through the TCR-CD3 complex or the TCR-CD3 and the CD28 molecule, we show that IL-10 is produced mainly by memory T lymphocytes after either way of stimulation and is drastically inhibited (70-90%) by cAMP elevating agents. cAMP mediated inhibition was reversed by the use of the specific PKA inhibitor Rp-8-Br-cAMP but not by the addition of exogenous rhIL-2, indicating that the inhibitory effect depends on PKA activation and is not secondary to IL-2 inhibition. Inhibition is taking place at both transcriptional and posttranscriptional level. Transfection of a luciferase reporter plasmid carrying the IL-10 promoter in T cells, revealed that TCR/CD28-induced activation was inhibited by 60% by cAMP elevation. The most sensitive part to cAMP mediated inhibition was a fragment of 135 bp upstream of TATA box, which contains multiple binding sites for MEF-2. Overexpression of MEF-2 in the same cells increased IL-10 promoter activity by 2.5-fold. Stimulation through TCR/CD28 increased MEF-2 binding in its corresponding binding sites which was inhibited by 80% in the presence of cAMP elevating agents. These results suggest that the inhibitory effect of cAMP on IL-10 production by normal peripheral T lymphocytes is cell type and stimulus specific, exerted on multiple levels and involves MEF2 transcription factor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19058854     DOI: 10.1016/j.molimm.2008.10.025

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  14 in total

1.  IL-10 -1082 SNP and IL-10 in primary CNS and vitreoretinal lymphomas.

Authors:  Hema L Ramkumar; De Fen Shen; Jingsheng Tuo; Rita M Braziel; Sarah E Coupland; Justine R Smith; Chi-Chao Chan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-25       Impact factor: 3.117

2.  Aging-related hyperinflammation in endotoxemia is mediated by the alpha2A-adrenoceptor and CD14/TLR4 pathways.

Authors:  Jennifer Leong; Mian Zhou; Asha Jacob; Ping Wang
Journal:  Life Sci       Date:  2010-03-17       Impact factor: 5.037

3.  Increased Retinal Ganglion Cell Survival by Exogenous IL-2 Depends on IL-10, Dopamine D1 Receptors, and Classical IL-2/IL-2R Signaling Pathways.

Authors:  Tamiris Gago Colares; Camila Saggioro de Figueiredo; Lucienne de Oliveira Jesus Souza; Aline Araujo Dos Santos; Elizabeth Giestal-de-Araujo
Journal:  Neurochem Res       Date:  2021-04-01       Impact factor: 3.996

4.  Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling.

Authors:  Sonemany Salinthone; Vijayshree Yadav; Robynn V Schillace; Dennis N Bourdette; Daniel W Carr
Journal:  PLoS One       Date:  2010-09-28       Impact factor: 3.240

5.  MEF2D sustains activation of effector Foxp3+ Tregs during transplant survival and anticancer immunity.

Authors:  Eros Di Giorgio; Liqing Wang; Yan Xiong; Tatiana Akimova; Lanette M Christensen; Rongxiang Han; Arabinda Samanta; Matteo Trevisanut; Tricia R Bhatti; Ulf H Beier; Wayne W Hancock
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

6.  Functional analysis of differences in transcriptional activity conferred by genetic variants in the 5' flanking region of the IL12RB2 gene.

Authors:  Nahoko Kato-Kogoe; Hideki Ohyama; Soichiro Okano; Koji Yamanegi; Naoko Yamada; Masaki Hata; Hiroshi Nishiura; Yoshimitsu Abiko; Nobuyuki Terada; Keiji Nakasho
Journal:  Immunogenetics       Date:  2015-11-09       Impact factor: 2.846

Review 7.  Pathological cardiac hypertrophy: the synergy of adenylyl cyclases inhibition in cardiac and immune cells during chronic catecholamine stress.

Authors:  Gabriel Komla Adzika; Jeremiah Ong'achwa Machuki; Wenkang Shang; Hongjian Hou; Tongtong Ma; Lijuan Wu; Juan Geng; Xide Hu; Xianluo Ma; Hong Sun
Journal:  J Mol Med (Berl)       Date:  2019-05-06       Impact factor: 4.599

Review 8.  Mechanism-Based Treatment Strategies for IBD: Cytokines, Cell Adhesion Molecules, JAK Inhibitors, Gut Flora, and More.

Authors:  Philipp Schreiner; Markus F Neurath; Siew C Ng; Emad M El-Omar; Ala I Sharara; Taku Kobayashi; Tadakazu Hisamatsu; Toshifumi Hibi; Gerhard Rogler
Journal:  Inflamm Intest Dis       Date:  2019-07-09

9.  MEF2 is an in vivo immune-metabolic switch.

Authors:  Rebecca I Clark; Sharon W S Tan; Claire B Péan; Urmas Roostalu; Valérie Vivancos; Kévin Bronda; Martina Pilátová; Jingqi Fu; David W Walker; Rebecca Berdeaux; Frédéric Geissmann; Marc S Dionne
Journal:  Cell       Date:  2013-09-26       Impact factor: 41.582

10.  TNF-α blockade induces IL-10 expression in human CD4+ T cells.

Authors:  Urmas Roostalu; Gina J Walter; Hayley G Evans; Nicola J Gullick; Klaus S Frederiksen; Ceri A Roberts; Jonathan Sumner; Dominique L Baeten; Jens G Gerwien; Andrew P Cope; Frederic Geissmann; Bruce W Kirkham; Leonie S Taams
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.